Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazole-3-acetic Acid
1. 71002-09-0
2. Zk-76604
3. Zk 76 604
4. Fwy2578lp5
5. 2-[4-(4-chlorophenyl)-1-(4-fluorophenyl)pyrazol-3-yl]acetic Acid
6. Zk-76 604
7. Pirazolaco
8. Pirazolacum
9. Pirazolacum [inn-latin]
10. Pirazolaco [inn-spanish]
11. Unii-fwy2578lp5
12. Pirazolac [usan:inn:ban]
13. Einecs 275-102-3
14. Pirazolac [inn]
15. Pirazolac [mi]
16. Pirazolac (usan/inn)
17. Pirazolac [usan]
18. Pirazolac [mart.]
19. Schembl153631
20. Chembl249446
21. Dtxsid00221233
22. 4-(p-chlorophenyl)-1-(p-fluorophenyl)pyrazole-3-acetic Acid
23. Zk 76604
24. Hy-100146
25. Cs-0018134
26. D05493
27. Q27278246
28. 1h-pyrazole-3-acetic Acid, 4-(4-chlorophenyl)-1-(4-fluorophenyl)-
29. [1-(4-fluorophenyl)-4-(4-chlorophenyl)-1h-pyrazol-3-yl]-acetic Acid
Molecular Weight | 330.7 g/mol |
---|---|
Molecular Formula | C17H12ClFN2O2 |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 330.0571335 g/mol |
Monoisotopic Mass | 330.0571335 g/mol |
Topological Polar Surface Area | 55.1 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 409 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Pirazolac manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pirazolac, including repackagers and relabelers. The FDA regulates Pirazolac manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pirazolac API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pirazolac supplier is an individual or a company that provides Pirazolac active pharmaceutical ingredient (API) or Pirazolac finished formulations upon request. The Pirazolac suppliers may include Pirazolac API manufacturers, exporters, distributors and traders.
click here to find a list of Pirazolac suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pirazolac DMF (Drug Master File) is a document detailing the whole manufacturing process of Pirazolac active pharmaceutical ingredient (API) in detail. Different forms of Pirazolac DMFs exist exist since differing nations have different regulations, such as Pirazolac USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pirazolac DMF submitted to regulatory agencies in the US is known as a USDMF. Pirazolac USDMF includes data on Pirazolac's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pirazolac USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pirazolac suppliers with USDMF on PharmaCompass.
Pirazolac Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pirazolac GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pirazolac GMP manufacturer or Pirazolac GMP API supplier for your needs.
A Pirazolac CoA (Certificate of Analysis) is a formal document that attests to Pirazolac's compliance with Pirazolac specifications and serves as a tool for batch-level quality control.
Pirazolac CoA mostly includes findings from lab analyses of a specific batch. For each Pirazolac CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pirazolac may be tested according to a variety of international standards, such as European Pharmacopoeia (Pirazolac EP), Pirazolac JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pirazolac USP).
LOOKING FOR A SUPPLIER?